DTCA and physician-patient interactions: The role of need-for-cognition and involvement.

Authors

  • Ignatius Fosu University of Arkansas

DOI:

https://doi.org/10.58997/smc.v33i2.34

Abstract

Direct-to-Consumer Advertising (DTCA) of prescription drugs leads to an increase in physician visits and initiated conversations about advertised drugs, with some patients asking doctors to prescribe the advertised drugs. However, it is largely unknown what types of patients engage in such behavior. To help address this issue, this study examined the role of involvement and need for cognition in talking to doctors and asking them to prescribe drugs in DTCA. Need-for-cognition and involvement were assessed with standardized scales and their impact on these behaviors as well as general responses to DTCA was assessed. Using FDA guidelines, print ads for three fictitious drugs were designed with the help of a professional graphic designer. Measures taken include attitude toward the ad, brand interest, purchase intention, and participants' behavior in relation to DTCA. Findings suggest that high involvement individuals were more likely to talk to doctors and ask them to prescribe DTCA drugs. An interaction effect of need-for-cognition and involvement impacted attitude toward the ad and purchase intention. Also, brand interest influenced both talking to doctors and asking doctors to prescribe. Patients who talk to doctors about DTCA drugs were more likely to ask them to prescribe the drugs. Based on the findings, recommendations were made for DTC advertisers. The findings from this study provide a basis for further exploring DTCA induced behavior.

References

Alperstein, N., & Peyrot, M. (1993). Consumer awareness of prescription drug advertising. Journal of Advertising Research, 33, 50-56.

Aikin, K. J. (2003). The impact of direct-to-consumer prescription drug advertising on the physician patient relationship. Retrieved from http://www.fda.gov/cder/ddmac/aikin/index.htm.

Aikin, K. J., Swasy, J. L., & Braman, A.C. (2004). Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs: Summary of FDA survey research results. Retrieved from http://www.fda.gov/cder/ddmac/Final%20Report/FRFinalExSu1119042.pdf.

An, S. (2007). Attitude toward Direct-to-Consumer advertising and drug inquiry intention: The moderating role of perceived knowledge. Journal of Health Communication, 12(6), 567-580.

Anderson, R. E., & Jolson, M. A. (1980). Technical wording in advertising: Implications for market segmentation. Journal of Marketing, 44, 57-66.

Bell, R.A., Wilkes, M.S. and Kravitz, R.L. (1999). Advertisement-induced prescription drug requests: Patients’ anticipated reactions to a physician who refuses. Journal of Family Practice. 48 (6), 446-52.

Booth-Kewley, S., & Vickers Jr., R. R. (1994). Associations between major domains of personality and health behavior. Journal of Personality, 62(3), 281-298.

Bradford, W. D., & Kleit, A. N. (2011). Can credence advertising effects be isolated? Can they be negative?: Evidence from pharmaceuticals. Southern Economic Journal. 78(1), 167-190.

Cacioppo, J. T., Petty, R. E., & Kao, C. F. (1984). The efficient assessment of need for cognition. Journal of Personality Assessment. 48, 306-307.

Cacioppo, J. T., Petty, R. E., Feinstein, J. A., & Jarvis, W. B. G. (1996). Dispositional differences in cognitive motivation: The life and times of individuals varying in need for cognition. Psychological Bulletin, 119, 197-253

Celsi, R. L., & Olson, J. C. (1988). The role of involvement in attention and comprehension processes. Journal of Consumer Research, 15, 210-224.

Cohen, E. P. (1988). Direct-to-the- public advertisement of prescription drugs. New England Journal of Medicine, 318, 373-376

DeLorme, D. E., Huh, J. & Reid, L. N. (2006). Perceived effects of Direct-to-Consumer (DTC) prescription drug advertising on self and others. Journal of Advertising, 35 (3), 47-65.

Deshpande, A. D., Menon, A. M., Perri, M., & Zinkhan, G. M. (2004). Direct-to-consumer advertising and its utility in health care decision making: A consumer perceptive. Journal of Health Communication, 9(6), 499–513.

Eagle, L., & Chamberlain, K. (2004). Prescription medication advertising: Professional discomfort and potential patient benefits: Can the two be balanced? International Journal of Advertising, 23, 69-90.

Elkin, E.B., Kim, S.H., Casper, E.S., Kissane, D.W. and Schrag, D. (2007). Desire for information and involvement in treatment decisions: elderly cancer patients’ preferences and their physicians’ perceptions. Journal of Clinical Oncology, Vol. 25 No. 33, 52755280. DTCA Physician-Patient Interactions 12

Fortuna, R. J., Ross-Degnan, D., Finkelstein, J., Fang, Z., Campion, F. X., & Simon, S. R. (2008). Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice. Journal of Evaluation in Clinical Practice, 14(6), 969973.

Gallo, L. C., & Matthews, K. A. (2003). Understanding the association between socioeconomic status and physical health: Do negative emotions play a role? Psychological Bulletin. 129, 10–51.

Gatti, J. (2003). Study: DTC ads are driving strong consumer awareness and response. Direct Marketing, Monday, December 1.

Gellad Z. F., & Lyles, K. W. (2007). Direct-to-consumer advertising of pharmaceuticals. American Journal of Medicine.;120(6):475–480.

Gotlieb, J. B., & Sarel, D. (1991). Comparative advertising effectiveness: The role of involvement and source credibility. Journal of Advertising, 20, 38-45.

Herzenstein, M., Misra, S., & Posavac, S. (2005). How consumers’ attitudes toward direct-to-consumer advertising of prescription drugs influence ad effectiveness, and consumer and physician behavior. Marketing Letters, 15(4), 201–212.

Hollon, M. (1999). Direct to consumer marketing of prescription drugs: Creating consumer demand. Journal of American Medical Association, 281, 382-384.

Holtz, W. (1998). Consumer-directed prescription drug advertising: Effects on public health. Journal of Law and Health. 13, 199-218.

Huh, J. (2003). Perceived effects, mediating influences, and behavioral outcomes of direct-to-consumer prescription drug advertising: Applying the third-person effect framework. Unpublished doctoral dissertation, University of Georgia, Athens, Georgia, USA.

Huh, J. & Becker, L. B. (2005). Direct-to-consumer prescription drug advertising: Understanding its consequences. International Journal of Advertising. 24(4), 441-466.

Joseph, M., Stone, G., Haper, J., Stockwell, E., Johnson, K., & Huckaby, J. (2005). The effect of manufacturer-to-consumer prescription drug advertisements: An exploratory investigation. Journal of Medical Marketing, 5, 233–244.

Kornfield, R., Alexander, G. C., Qato, D. M., Kim, Y., Hirsch, J. D., & Emery, S. L. (2015). Trends in exposure to televised prescription drug advertising, 2003–2011. American Journal of Preventive Medicine, 48(5), 575-579.

Laczniak, R. N., Kempf, D. S. & Muehling, D. D. (1999). Advertising message involvement: The role of enduring and situational factors. Journal of Current Issues and Research in Advertising, 21(1), 51-61.

Lee, D. & Emmett, D (2012). Prescription drug request and denial. International Journal of Pharmaceutical and Healthcare Marketing, 6 (3), 200-214.

Lee, B., Salmon, C. T., & Hye-Jin, P. (2007). The effects of information sources on consumer reactions to Direct-to-Consumer prescription drug advertising. Journal of Advertising, 36(1), 107-119.

Machleit, K. A., Allen, C., & Madden, T. (1993). The mature brand and brand interest: An alternative consequence of ad-evoked affect. Journal of Marketing, 57(4), 72-82.

MacKenzie, S. B., Lutz, R. J., & Belch, G. E. (1986). The role of attitude toward the ad as a mediator of advertising effectiveness: A test of competing explanations, Journal of Marketing Research, 23, 130-143. DTCA Physician-Patient Interactions 13

McGrath, J. M. & Mahood, C. (2004). The impact of arousing programming and product involvement on advertising effectiveness. Journal of Current Issues & Research in Advertising. 26(2), 41-52.

Mehta, A., & Purvis, S. C. (2003). Consumer response to print prescription drug advertising. Journal of Advertising Research, 43, 194-206.

Menon, A. M., Deshpande, A. D., Zinkhan, G. M., & Perri, M. (2004). A model assessing the effectiveness of direct-to-consumer advertising: Integration of concepts and measures from marketing and healthcare. International Journal of Advertising, 23, 91-118.

Mouchawar, J., Hensley-Alford, S., Laurion, S., Ellis, J., Kulchak-Rahm, A., Finucane, M.L., et al. (2005). Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: A naturally-occurring experiment. Genetics in Medicine, 7(3), 191–197

Myers S. D., Royne, M. B., & Deitz G. D. (2011). Direct-to-consumer advertising: Exposure, behavior, and policy implications. Journal of Public Policy and Marketing, 30(1), pp. 110–118.

Paul, D. P., Handlin, A., & Stanton, A. D. (2002). Primary care physicians’ attitudes toward direct-to-consumer advertising of prescription drugs: Still crazy after all these years. Journal of Consumer Marketing,19, 564-574.

Perri III, M., & Nelson, A. A. (1987). An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription drugs. Journal of Health Care Marketing, 7, 1017.

Petty, R.E., & Cacioppo, J. T. (1979). Issue involvement can increase or decrease persuasion by enhancing message relevant cognitive responses. Journal of Personality and Social Psychology, 37, 1915-1926.

Petty, R. E., Cacioppo, J. T., & Goldman, R. (1981). Personal involvement as a determinant of argument-based persuasion. Journal of Personality and Social Psychology, 41, 847-855.

Petty, R. E & Cacioppo, J. T. (1984). The elaboration likelihood model of persuasion. Advances in Consumer Research, 11, 673–675.

Peyrot, M., Alperstein, N. M., Van Doren, D., & Poli, L. G. (1998). Direct-to-consumer ads can influence behavior. Marketing Health Services, 18, 26-32.

Pharmaceutical Research and Manufacturers of America (2002). Direct-to-consumer advertising strengthens our healthcare system. Retrieved from http://www.phrma.org/publications/publications//2002-11-11.616.PDF

Putrevu, S., Tan, J., & Lord, K. R. (2004). Consumer responses to complex advertisements: The moderating role of need for cognition, knowledge, and gender. Journal of Current Issues and Research in Advertising. 26, 9-23.

Singh, T. & Smith, D. (2005). Direct-to-consumer prescription drug advertising: A study of consumer attitudes and behavioral intentions. Journal of Consumer Marketing, 22(7), 369–378.

t’Hoen, E. (1998). Direct to consumer advertising: For better profits or for better health? American Journal of Health System Pharmacy, 55, 594-597

Wilkes, M. S., Bell, R. A., & Kravitz, R. (2000). Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs, 19, 110-128.

Zaichkowsky, J. L. (1985). Measuring the involvement construct. Journal of Consumer Research, 341-352. DTCA Physician-Patient Interactions.

Zaichkowsky, J. L. (1994). The personal involvement inventory: Reduction, revision, and application to advertising. Journal of Advertising, 23, 59-70.

Downloads

Published

2019-06-04

Issue

Section

Articles